相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG
Eric Salazar et al.
AMERICAN JOURNAL OF PATHOLOGY (2021)
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
R. Libster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
M. J. Joyner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
V. A. Simonovich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC
Hyun ah Yoon et al.
JCI INSIGHT (2021)
Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19
Purbita Bandopadhyay et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Neutralizing Antibody LY-CoV555 for Outpatient Covid-19
Arturo Casadevall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers
Eshan U. Patel et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2021)
Anti-HIV-1 antibodies trigger non-lytic complement deposition on infected cells
Jeremy Dufloo et al.
EMBO REPORTS (2020)
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
Pavlo Gilchuk et al.
IMMUNITY (2020)
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
Daniel Wrapp et al.
CELL (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto et al.
NATURE (2020)
Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality
Eric Salazar et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment
Jing Sun et al.
CELL (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
Michael J. Joyner et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
Wafaa B. Alsoussi et al.
JOURNAL OF IMMUNOLOGY (2020)
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients
Michael J. Joyner et al.
MAYO CLINIC PROCEEDINGS (2020)
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
Masaki Imai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Xiangyang Chi et al.
SCIENCE (2020)
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Alina Baum et al.
SCIENCE (2020)
Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework
Liise-anne Pirofski et al.
MBIO (2020)
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
Sabra Klein et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study
Sean T. H. Liu et al.
NATURE MEDICINE (2020)
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
Anup Agarwal et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
The Assessment of Convalescent Plasma Efficacy against COVID-19
Arturo Casadevall et al.
MED (2020)
Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma
Yasmin Maor et al.
ECLINICALMEDICINE (2020)
Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants
Arne Ohlsson et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)
Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial
John H. Beigel et al.
LANCET RESPIRATORY MEDICINE (2019)
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
Sabue Mulangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study
John H. Beigel et al.
LANCET INFECTIOUS DISEASES (2018)
IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity
Taia T. Wang et al.
SCIENCE (2017)
Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection
Bernhard Resch
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine
Rafael Prados-Rosales et al.
PLOS PATHOGENS (2017)
Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea
J. van Griensven et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Role of B Cells and Antibodies in Acquired Immunity against Mycobacterium tuberculosis
Jacqueline M. Achkar et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Disease-Enhancing Antibodies Improve the Efficacy of Bacterial Toxin-Neutralizing Antibodies
Siu-Kei Chow et al.
CELL HOST & MICROBE (2013)
A new synthesis for antibody-mediated immunity
Arturo Casadevall et al.
NATURE IMMUNOLOGY (2012)
Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
Ivan F. N. Hung et al.
CLINICAL INFECTIOUS DISEASES (2011)
Meta-analysis: Convalescent blood products for Spanish influenza pneumonia: A future H5N1 treatment?
Thomas C. Luke et al.
ANNALS OF INTERNAL MEDICINE (2006)
A novel glyco-conjugate vaccine against fungal pathogens
A Torosantucci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
SARS-coronavirus replication in human peripheral monocytes/macrophages
M Yilla et al.
VIRUS RESEARCH (2005)
Use of convalescent plasma therapy in SARS patients in Hong Kong
Y Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Passive antibody therapy for infectious diseases
A Casadevall et al.
NATURE REVIEWS MICROBIOLOGY (2004)
The damage-response framework of microbial pathogenesis
A Casadevall et al.
NATURE REVIEWS MICROBIOLOGY (2003)
More is not necessarily better: Prozone-like effects in passive immunization with IgG
CP Taborda et al.
JOURNAL OF IMMUNOLOGY (2003)
Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies
MB Zwick et al.
JOURNAL OF VIROLOGY (2001)
Immunoglobulin m efficacy against Cryptococcus neoformans:: Mechanism, dose dependence, and prozone-like effects in passive protection experiments
CP Taborda et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
